World's Best Scientists 2026 revealed!
VIEW LIST
Tadeusz Robak

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 90 12026 11314 15 14 873 39977

Tadeusz Robak publications per year

The chart shows the history of publications by Tadeusz Robak between 1980 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Tadeusz Robak published across 47 years, from 1980 to 2026, averaging 21.3 papers a year. Output peaked at 55 publications in 2015. 32 of the 1,003 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1980 to 2026. Vertical axis: number of publications, 0 to 55. Peak 55 publications in 2015. 1980: 1 publication 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 2 publications 1986: 1 publication 1987: 1 publication 1988: 0 publications 1989: 1 publication 1990: 0 publications 1991: 2 publications 1992: 3 publications 1993: 0 publications 1994: 7 publications 1995: 4 publications 1996: 9 publications 1997: 8 publications 1998: 8 publications 1999: 8 publications 2000: 9 publications 2001: 15 publications 2002: 28 publications 2003: 15 publications 2004: 36 publications 2005: 41 publications 2006: 39 publications 2007: 40 publications 2008: 33 publications 2009: 45 publications 2010: 41 publications 2011: 36 publications 2012: 32 publications 2013: 48 publications 2014: 39 publications 2015: 55 publications 2016: 32 publications 2017: 39 publications 2018: 32 publications 2019: 40 publications 2020: 33 publications 2021: 47 publications 2022: 46 publications 2023: 54 publications 2024: 41 publications 2025: 31 publications 2026: 1 publication
1980 2026

1,003 publications in total across all disciplines

View publications per year as a table
Tadeusz Robak: publications per year, 1980 to 2026
Year Publications
1980 1
1981 0
1982 0
1983 0
1984 0
1985 2
1986 1
1987 1
1988 0
1989 1
1990 0
1991 2
1992 3
1993 0
1994 7
1995 4
1996 9
1997 8
1998 8
1999 8
2000 9
2001 15
2002 28
2003 15
2004 36
2005 41
2006 39
2007 40
2008 33
2009 45
2010 41
2011 36
2012 32
2013 48
2014 39
2015 55
2016 32
2017 39
2018 32
2019 40
2020 33
2021 47
2022 46
2023 54
2024 41
2025 31
2026 1
Total 1,003
Download as CSV

Tadeusz Robak publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tadeusz Robak sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 861–880 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 873 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155 873
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Tadeusz Robak D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tadeusz Robak sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 90–91 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922 90
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Tadeusz Robak is affiliated with the Medical University of Lodz in Poland. Their research primarily focuses on the field of Medicine with a strong emphasis on several key subfields, including Genetics, Pathology and Forensic Medicine, Hematology, Immunology, and Oncology.

The main topics covered by their work include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Acute Lymphoblastic Leukemia research
  • Protein Degradation and Inhibitors

Robak has published extensively, with a notable presence in various specialized venues. The most frequent publication venues include:

  • Blood
  • Acta Haematologica Polonica
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Leukemia & lymphoma/Leukemia and lymphoma

Among recent papers relevant to their field are:

  • Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial, 2021, Journal of Clinical Oncology
  • Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2020, Annals of Oncology
  • Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia, 2022, New England Journal of Medicine
  • Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial, 2022, The Lancet Oncology
  • Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia, 2022, Blood Advances

Collaborations have been a consistent feature of Robak's research career, with frequent coauthors including:

  • Paweł Robak
  • Paolo Ghia
  • Wojciech Jurczak
  • Jennifer R. Brown
  • Constantine S. Tam

Best Publications

  • Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

    J. C. Byrd;J. R. Brown;Susan O'Brien;J. C. Barrientos

  • Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

    Jan A. Burger;Alessandra Tedeschi;Paul M. Barr;Tadeusz Robak

  • iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

    Philippe Moreau;Halyna Pylypenko;Sebastian Grosicki;Ievgenii Karamanesht

  • Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

    John F. Seymour;Thomas J. Kipps;Barbara Eichhorst;Peter Hillmen

  • Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

    Robert Z. Orlowski;Arnon Nagler;Pieter Sonneveld;Joan Bladé

  • Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

    Hagop M. Kantarjian;Neil P. Shah;Jorge E. Cortes;Michele Baccarani

  • Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

    Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook

  • Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

    William G. Wierda;Thomas J. Kipps;Jiří Mayer;Stephan Stilgenbauer

  • Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic Leukemia

    Peter Hillmen;Aleksander B. Skotnicki;Tadeusz Robak;Branimir Jaksic

  • Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

    Tadeusz Robak;Anna Dmoszynska;Philippe Solal-Céligny;Krzysztof Warzocha

  • Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study.

    Bertrand Coiffier;Stéphane Lepretre;Lars Møller Pedersen;Ole Gadeberg

  • Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial.

    Hagop M Kantarjian;Ricardo Pasquini;Nelson Hamerschlak;Philippe Rousselot

  • Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

    Jorge E. Cortes;Florian H. Heidel;Andrzej Hellmann;Walter Fiedler

  • Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

    Jan A. Burger;Paul M. Barr;Tadeusz Robak;Carolyn Owen

  • Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

    Tadeusz Robak;Huiqiang Huang;Jie Jin;Jun Zhu

  • Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

    Peter Hillmen;Tadeusz Robak;Ann Janssens;K Govind Babu

  • Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.

    John C Byrd;Peter Hillmen;Paolo Ghia;Arnon P Kater

  • Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia

    Robert J. Kreitman;Martin S. Tallman;Tadeusz Robak;Steven Coutre

  • First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.

    Anton Hagenbeek;Ole Vestergaard Gadeberg;Peter Johnson;Lars Møller Pedersen

Frequent Co-Authors

Peter Hillmen
Peter Hillmen St James's University Hospital
Thomas J. Kipps
Thomas J. Kipps University of California, San Diego
Steven Coutre
Steven Coutre Stanford University
Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Jan A. Burger
Jan A. Burger The University of Texas MD Anderson Cancer Center
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna
Jennifer R. Brown
Jennifer R. Brown Harvard University
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Susan O'Brien
Susan O'Brien University of California, Irvine
Arnon Nagler
Arnon Nagler Sheba Medical Center

External Links

Personal website of Tadeusz Robak

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine or a related healthcare field, there are a range of online degrees and specialized certificates that can broaden your opportunities. For those interested in advanced nursing roles, pursuing the cheapest dnp program can be a cost-effective way to achieve leadership positions in nursing practice.

Pharmacists are always in demand, and you can begin your journey by exploring accredited online pharmd programs that offer flexibility and affordability for busy professionals. If you are more interested in the management and organization of health data, enrolling in an him degree online can open up roles in healthcare administration, data management, and compliance.

Additionally, for those seeking quick entry into the healthcare workforce, medical billing and coding online courses provide practical skills that can lead to remote or office-based positions. By exploring these diverse, affordable online options, you can find a pathway in healthcare that fits your interests and career goals.

Best Scientists Citing Tadeusz Robak

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 162

Michael Hallek

Michael Hallek

University of Cologne

Publications: 156

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 140

John C. Byrd

John C. Byrd

University of Pittsburgh Cancer Institute

Publications: 121

William G. Wierda

William G. Wierda

The University of Texas MD Anderson Cancer Center

Publications: 118

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 115

Stephan Stilgenbauer

Stephan Stilgenbauer

University of Ulm

Publications: 96

Constantine S. Tam

Constantine S. Tam

University of Melbourne

Publications: 92

Michael J. Keating

Michael J. Keating

The University of Texas MD Anderson Cancer Center

Publications: 89

Jennifer R. Brown

Jennifer R. Brown

Harvard University

Publications: 87

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 80

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 79

Jan A. Burger

Jan A. Burger

The University of Texas MD Anderson Cancer Center

Publications: 76

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 72

Alessandra Ferrajoli

Alessandra Ferrajoli

The University of Texas MD Anderson Cancer Center

Publications: 72

John F. Seymour

John F. Seymour

Peter MacCallum Cancer Centre

Publications: 70

Trending Scientists

Frans A. Krens

Frans A. Krens

Wageningen University & Research

Linda C. Giudice

Linda C. Giudice

University of California, San Francisco

Natalia Stambulova

Natalia Stambulova

Halmstad University

Franco Molteni

Franco Molteni

European Centre for Medium-Range Weather Forecasts

Martin Junginger

Martin Junginger

Utrecht University

Michael H. Young

Michael H. Young

The University of Texas at Austin

Henry D. Jacoby

Henry D. Jacoby

MIT

Jeffrey K. Actor

Jeffrey K. Actor

The University of Texas Health Science Center at Houston

Brian F. Yates

Brian F. Yates

University of Tasmania

Raimund Bleischwitz

Raimund Bleischwitz

University College London

Victor Moreno

Victor Moreno

University of Barcelona

Augustus D. Mazzocca

Augustus D. Mazzocca

Harvard Medical School

Frank Sundler

Frank Sundler

Lund University

Ronen Kadmon

Ronen Kadmon

Hebrew University of Jerusalem

Lynn B. Martin

Lynn B. Martin

University of South Florida

Jenifer E. Dugan

Jenifer E. Dugan

University of California, Santa Barbara

Related Medicine Rankings & Guides

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
2027 Most Affordable Online Master's Degrees in Nutrition

2027 Most Affordable Online Master's Degrees in Nutrition
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 Best Shortest Online PMHNP Certificate Programs

2027 Best Shortest Online PMHNP Certificate Programs
2027 Best PharmD Accelerated Degree Programs

2027 Best PharmD Accelerated Degree Programs
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
2027 Best Online Associate in Health Sciences

2027 Best Online Associate in Health Sciences
September 2027 Best Online Kinesiology Programs

September 2027 Best Online Kinesiology Programs
2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus
2027 Best Second-Degree BSN Programs

2027 Best Second-Degree BSN Programs
2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs

2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs
2027 Best Online CAHIIM-Accredited Health Information Management Degree Programs

2027 Best Online CAHIIM-Accredited Health Information Management Degree Programs
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
2027 Easiest Nurse Midwife Programs to Get Into

2027 Easiest Nurse Midwife Programs to Get Into
2027 Fastest Doctor of Nursing Practice (DNP) Degree Programs

2027 Fastest Doctor of Nursing Practice (DNP) Degree Programs
2027 Most Affordable Online Certified Nursing Assistant (CNA) Programs

2027 Most Affordable Online Certified Nursing Assistant (CNA) Programs
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Cost of LPN Programs & Schools

2027 Cost of LPN Programs & Schools
2027 Fastest Online Medical Billing and Coding Certificate Programs

2027 Fastest Online Medical Billing and Coding Certificate Programs
2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus

Recently Published Articles

2027 Best Online Graduate Certificate Programs in Counseling

2027 Best Online Graduate Certificate Programs in Counseling
2027 Online Human Services Degree Master's Programs That Accept FAFSA

2027 Online Human Services Degree Master's Programs That Accept FAFSA
2027 Cheapest Online Public Safety Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Public Safety Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Credit Requirements for a Healthcare Management Degree Explained

2027 Credit Requirements for a Healthcare Management Degree Explained
2027 Different Types of Information Systems Degrees and Their Salaries

2027 Different Types of Information Systems Degrees and Their Salaries
2027 How to Become an Elementary School Teacher in Maryland: Requirements & Certification

2027 How to Become an Elementary School Teacher in Maryland: Requirements & Certification
2027 Are Online Forensic Science Degrees Respected by Employers?

2027 Are Online Forensic Science Degrees Respected by Employers?
2027 Communication Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Communication Degree Coursework Explained: What Classes Can You Expect to Take?
2027 Cheapest Way to Get a Teaching Credential in Port St. Lucie, FL: Degree Requirements & Certification

2027 Cheapest Way to Get a Teaching Credential in Port St. Lucie, FL: Degree Requirements & Certification
2027 Best Bachelor's Degrees for Remote Jobs

2027 Best Bachelor's Degrees for Remote Jobs
2027 Competency-Based Online Elementary Education Master's Degrees

2027 Competency-Based Online Elementary Education Master's Degrees
2027 Is a Theology Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is a Theology Master's Degree Worth It? ROI, Salary & Career Impact
2027 What Can You Do With a Doctorate Degree in Organizational Leadership

2027 What Can You Do With a Doctorate Degree in Organizational Leadership
2027 Healthcare Administration Degree vs. Certificate: Which Should You Choose?

2027 Healthcare Administration Degree vs. Certificate: Which Should You Choose?
2027 How to Pay for an Early Childhood Education Master's Degree with Financial Aid

2027 How to Pay for an Early Childhood Education Master's Degree with Financial Aid
2027 How To Become a Phlebotomist in Colorado

2027 How To Become a Phlebotomist in Colorado
2027 Trades Careers: Guide to Career Paths, Options & Salary

2027 Trades Careers: Guide to Career Paths, Options & Salary
2027 Fastest Online MBA Programs in Entrepreneurship

2027 Fastest Online MBA Programs in Entrepreneurship
2027 Substitute Teaching License & Requirements in Delaware

2027 Substitute Teaching License & Requirements in Delaware
2027 Highest Paying Careers With an Information Technology Bachelor's Degree

2027 Highest Paying Careers With an Information Technology Bachelor's Degree
2027 What Prerequisites Do You Need for a Fine Arts Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for a Fine Arts Degree? Entry Requirements, Credits & Eligibility Rules